MedTrace Logo

A Prognostic Tool for Early Stage CLL

NCT03436524 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4933

Last updated 2021-09-16

No results posted yet for this study

Summary

The study aims at developing a model for the prediction of time to first treatment in chronic lymphocytic leukemia patients presenting with asymptomatic early stage disease

Conditions

Sponsors & Collaborators

  • Azienda Ospedaliero Universitaria Maggiore della Carita

    collaborator OTHER

  • Oncology Institute of Southern Switzerland

    lead OTHER

Principal Investigators

  • Davide Rossi, MD, PhD · Oncology Institute of Southern Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-02-28
Completion
2020-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436524 on ClinicalTrials.gov